ATI RN
ATI RN Exit Exam
1. What is the best intervention for a patient experiencing hypoxia?
- A. Administer oxygen
- B. Reposition the patient
- C. Provide humidified air
- D. Provide chest physiotherapy
Correct answer: A
Rationale: The best intervention for a patient experiencing hypoxia is to administer oxygen. Oxygen therapy helps improve oxygenation levels in the blood, addressing the underlying cause of hypoxia. Repositioning the patient, providing humidified air, and chest physiotherapy may be beneficial in certain situations but are not the primary interventions for hypoxia. Administering oxygen is crucial to quickly alleviate hypoxia and support the patient's respiratory function.
2. How should a healthcare professional monitor a patient receiving IV potassium?
- A. Monitor urine output
- B. Check blood pressure
- C. Monitor IV site
- D. Check respiratory rate
Correct answer: C
Rationale: When a patient is receiving IV potassium, it is crucial to monitor the IV site. Potassium can be irritating to the veins and may cause phlebitis or infiltration. Monitoring the IV site allows early detection of any potential complications. Checking urine output (Choice A) is important to assess kidney function but is not directly related to monitoring IV potassium. Blood pressure (Choice B) and respiratory rate (Choice D) are essential vital signs to monitor in general patient care but are not specific to monitoring IV potassium administration.
3. Which lab value should be monitored in patients receiving heparin therapy?
- A. Monitor aPTT
- B. Monitor INR
- C. Monitor platelet count
- D. Monitor sodium levels
Correct answer: A
Rationale: The correct answer is to monitor aPTT in patients receiving heparin therapy. Activated Partial Thromboplastin Time (aPTT) is crucial to assess the therapeutic effectiveness of heparin and to prevent bleeding complications. Monitoring INR (Choice B) is more relevant for patients on warfarin therapy, not heparin. Platelet count (Choice C) monitoring is essential for detecting heparin-induced thrombocytopenia rather than assessing heparin therapy itself. Monitoring sodium levels (Choice D) is not directly related to heparin therapy monitoring.
4. A healthcare provider is performing a skin assessment for a client and observes several skin lesions. Which of the following findings is a priority to report to the provider?
- A. Raised nevus
- B. Macule
- C. Vesicle
- D. Irregularly shaped mole
Correct answer: D
Rationale: An irregularly shaped mole is a priority finding to report to the provider as it can be indicative of melanoma, a type of skin cancer. Melanoma is a serious condition that requires prompt evaluation and treatment. Raised nevus, macule, and vesicle are common skin findings that are typically benign and may not require immediate attention. Therefore, the irregularly shaped mole stands out as the priority due to its association with potential malignancy.
5. How should a healthcare professional monitor a patient on furosemide for fluid balance?
- A. Monitor daily weight
- B. Check for edema
- C. Monitor input and output
- D. Monitor blood pressure
Correct answer: A
Rationale: Monitoring a patient's daily weight is crucial when assessing fluid balance in individuals prescribed furosemide. Furosemide is a diuretic that helps the body eliminate excess fluid and salt. Changes in weight can reflect fluid shifts, making daily weight monitoring a reliable indicator of fluid status. While checking for edema and monitoring input and output are essential aspects of fluid balance assessment, they may not provide as immediate and quantifiable information as daily weight measurements. Monitoring blood pressure is important in patients on furosemide due to its potential to affect blood pressure levels, but it is not as directly indicative of fluid balance as daily weight monitoring.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access